Dr. Ryan Bethencourt serves as Chief Executive Officer at Wild Earth. He is a Co-Founder and serves as Chief Executive Officer of Wild Earth. He serves as Advisor at Ahimsa VC. He also serves as Board Member at Provectus Algae. Dr. Bethencourt serves as Advisor and Board Member at Jellatech. He serves as Chairman and Advisor at Tiamat Sciences. Dr. Bethencourt is also a Co-Founder and serves as Managing Partner at Sustainable Food Ventures. He also serves as Director and Advisor at Jellatech. He also serves as Advisor at Big Idea Ventures and Evo Foods. He also is an Angel Investor. Dr. Bethencourt also serves as Partner at BABEL Ventures. He previously served as a Program Director and Venture Partner at IndieBio. He has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs from first IND submission to FDA approval with many major biopharma's including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, Genentech, and other companies in the U.S., E.U., and Japan. He's also served as COO at Genescient Pharmaceuticals, a longevity focused biotech startup and CEO of Halpin Neurosciences, an ALS focused startup. His work has been featured in Wired, TechCrunch, Forbes, the San Francisco Business Times, and other publications. He regularly speaks on biotech innovation and writes for Biocoder, an O'Reilly Media publication. He has a Ph.D degree from University of Edinburgh, Scotland in 2003. He served at Advisor at Blue Horizon Corporation. He is a scientist and entrepreneur best known for his work as co-founder and CEO of Wild Earth, Partner at Babel Ventures and co-founder and former Program Director at IndieBio, an accelerator and early stage seed fund. He and his team have funded 68+ startups.